Primary medical therapy for acromegaly.

Research output: Contribution to journalArticle

Standard

Primary medical therapy for acromegaly. / Sheppard, Michael.

In: Clinical Endocrinology, Vol. 58, No. 4, 01.04.2003, p. 387-99.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{b721eecddcdc42ad988dce17d66f337c,
title = "Primary medical therapy for acromegaly.",
abstract = "There is now considerable evidence that the clinical outcome in patients with acromegaly can be improved very substantially by means of better surgical expertise and effective medical therapies used in a flexible and innovative manner. Medical therapy alone in patients who have not undergone surgery or radiotherapy (primary medical therapy) offers the prospect of near normalisation of GH/IGF-I levels together with substantial tumour shrinkage in a significant number of patients.",
author = "Michael Sheppard",
year = "2003",
month = apr,
day = "1",
language = "English",
volume = "58",
pages = "387--99",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley",
number = "4",

}

RIS

TY - JOUR

T1 - Primary medical therapy for acromegaly.

AU - Sheppard, Michael

PY - 2003/4/1

Y1 - 2003/4/1

N2 - There is now considerable evidence that the clinical outcome in patients with acromegaly can be improved very substantially by means of better surgical expertise and effective medical therapies used in a flexible and innovative manner. Medical therapy alone in patients who have not undergone surgery or radiotherapy (primary medical therapy) offers the prospect of near normalisation of GH/IGF-I levels together with substantial tumour shrinkage in a significant number of patients.

AB - There is now considerable evidence that the clinical outcome in patients with acromegaly can be improved very substantially by means of better surgical expertise and effective medical therapies used in a flexible and innovative manner. Medical therapy alone in patients who have not undergone surgery or radiotherapy (primary medical therapy) offers the prospect of near normalisation of GH/IGF-I levels together with substantial tumour shrinkage in a significant number of patients.

M3 - Article

C2 - 12641619

VL - 58

SP - 387

EP - 399

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 4

ER -